These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 874623)
1. 2-Methyl-3-butyn-2-ol as an acetylene precursor in the Mannich reaction. A new synthesis of suicide inactivators of monoamine oxidase. Fowler JS J Org Chem; 1977 Jul; 42(15):2637-7. PubMed ID: 874623 [No Abstract] [Full Text] [Related]
2. Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B. Silvestri R; La Regina G; De Martino G; Artico M; Befani O; Palumbo M; Agostinelli E; Turini P J Med Chem; 2003 Mar; 46(6):917-20. PubMed ID: 12620068 [TBL] [Abstract][Full Text] [Related]
3. Acetylenic and allenic derivatives of 2-(1-methylindolyl) methylamine as selective inhibitors of the monoamine oxidases A and B. Cruces MA; Elorriaga C; Fernandez Alvarez E; Lopez Chico MT; Nieto Lopez O Farmaco Sci; 1988; 43(7-8):567-73. PubMed ID: 3224706 [TBL] [Abstract][Full Text] [Related]
4. 5-(Aminomethyl)-3-aryldihydrofuran-2(3H)-ones, a new class of monoamine oxidase-B inactivators. Ding Z; Silverman RB J Med Chem; 1992 Mar; 35(5):885-9. PubMed ID: 1548678 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologically active acetylene compounds. II. Propynyl-substituted indole derivatives. Neumeyer JL; Moyer UV; Leonard JE J Med Chem; 1969 May; 12(3):450-2. PubMed ID: 5788161 [No Abstract] [Full Text] [Related]
6. Alkynyl-coumarinyl ethers as MAO-B inhibitors. Mertens MD; Hinz S; Müller CE; Gütschow M Bioorg Med Chem; 2014 Mar; 22(6):1916-28. PubMed ID: 24560738 [TBL] [Abstract][Full Text] [Related]
7. New analogues of N-(2-aminoethyl)-4-chlorobenzamide (Ro 16-6491). Some of the most potent monoamine oxidase-B inactivators. Annan N; Silverman RB J Med Chem; 1993 Nov; 36(24):3968-70. PubMed ID: 8254625 [TBL] [Abstract][Full Text] [Related]
8. Transformation of heterocyclic reversible monoamine oxidase-B inactivators into irreversible inactivators by N-methylation. Ding CZ; Silverman RB J Med Chem; 1993 Nov; 36(23):3606-10. PubMed ID: 8246228 [TBL] [Abstract][Full Text] [Related]
9. Oxazolidinones, dihydrofuranones, and pyrrolidinones as inactivators and substrates of monoamine oxidase B: approaches to the design of antiparkinsonian agents. Silverman RB Farmaco; 1997 May; 52(5):343-52. PubMed ID: 9274004 [No Abstract] [Full Text] [Related]
11. The inhibition of rat brain monoamine oxidase-B by J-508 (N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride), and its use for the titration of this enzyme form. Fowler CJ; Oreland L; Wiberg A; Carlsson A; Magnusson T Med Biol; 1979; 57(6):406-11. PubMed ID: 547123 [TBL] [Abstract][Full Text] [Related]
12. [Synthesis of N-methyl-N-(2-propynyl)-benzylamine and its o-bromo- and o-chloro derivatives, monoamine oxidase inhibitors]. Simon IB; Vvedenskiĭ VP; Chekman IS Med Prom SSSR; 1966 Jan; 20(1):8-10. PubMed ID: 5984475 [No Abstract] [Full Text] [Related]
13. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors. Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214 [TBL] [Abstract][Full Text] [Related]
14. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogues. Inactivation of monoamine oxidase by conformationally rigid analogues of N,N-dimethylcinnamylamine. Hiebert CK; Silverman RB J Med Chem; 1988 Aug; 31(8):1566-70. PubMed ID: 3260955 [TBL] [Abstract][Full Text] [Related]
15. Ligand accelerated indium(III)-catalyzed asymmetric alkynylation of aldehydes with 2-methyl-3-butyn-2-ol as an ethyne equivalent donor. Harada S; Takita R; Ohshima T; Matsunaga S; Shibasaki M Chem Commun (Camb); 2007 Mar; (9):948-50. PubMed ID: 17311130 [TBL] [Abstract][Full Text] [Related]
16. Transformation of monoamine oxidase-B primary amine substrates into time-dependent inhibitors. Tertiary amine homologues of primary amine substrates. Ding CZ; Lu X; Nishimura K; Silverman RB J Med Chem; 1993 Jun; 36(12):1711-5. PubMed ID: 8510099 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and selective monoamine oxidase B-inhibiting properties of 1-methyl-1,2,3,6-tetrahydropyrid-4-yl carbamate derivatives: potential prodrugs of (R)- and (S)-nordeprenyl. Flaherty P; Castagnoli K; Wang YX; Castagnoli N J Med Chem; 1996 Nov; 39(24):4756-61. PubMed ID: 8941389 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents. Kumar B; Kumar M; Dwivedi AR; Kumar V ChemMedChem; 2018 Apr; 13(7):705-712. PubMed ID: 29534334 [TBL] [Abstract][Full Text] [Related]
19. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties. Li Y; Qiang X; Luo L; Yang X; Xiao G; Zheng Y; Cao Z; Sang Z; Su F; Deng Y Bioorg Med Chem; 2017 Jan; 25(2):714-726. PubMed ID: 27923535 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors. Abdelhafez OM; Amin KM; Ali HI; Abdalla MM; Batran RZ J Med Chem; 2012 Dec; 55(23):10424-36. PubMed ID: 23153282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]